Diotheris
Signal active
Organization
Contact Information
Overview
Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria. The company's products are based on live bacteria includes NASOFLORE which targets Staphylococcus aureus, enabling the prevention of infections due to major pathogen and protecting patients against biological threats.
About
Industries
Biotechnology, Life Science, Therapeutics
Founded
2020
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Diotheris headquartered in Europe, operates in the Biotechnology, Life Science, Therapeutics sector. With a team of 1-10 employees, Diotheris is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Diotheris, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$0
Details
1
Diotheris has raised a total of $0 in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed |
Investors
Diotheris is funded by 2 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Diotheris | - | FUNDING ROUND - Diotheris | undefined |
| InnoBio Fund | - | FUNDING ROUND - InnoBio Fund | undefined |
Recent Activity
There is no recent news or activity for this profile.